Abstract: Compounds of formula (I) are suitable for the production of pharmaceuticals for the prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading metalloproteinases is involved.

Abstract: The invention features methods for induction of angiogenesis by administration of nicotine or other nicotine receptor agonist. Induction of angiogenesis by the methods of the invention can be used in therapeutic angiogenesis in, for example, treatment of ischemic syndromes such as coronary or peripheral arterial disease.

Abstract: The present invention relates to novel hydroxyethylene compounds having Asp2 (?-secretase. BACE1 or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated ?-amyloid levels or ?-amyloid deposits, particularly Alzheimer's disease.

Abstract: The invention related to novel compounds of Formula (I) or a salt, solvate or prodrug thereof, wherein R1, R2, R3, n and m are as described in the specification, useful in the treatment of a disease or condition mediated through glucokinase (GLK), such as type 2 diabetes. The invention also relates to methods for preparing compounds of Formula (I) and their use as medicaments in the treatment of diseases mediated by glucokinase.

Abstract: Pleuromutilin compounds of the formula: are of use in anti-bacterial therapy.

Abstract: A series of dynamic platinum compounds for cancer treatment are described. The compounds may become active and inactive reversibly.

Abstract: A novel class of tricyclic compounds of the following formula (I) is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of Inflammatory Diseases such as septic shock.

Abstract: The provides compounds for the treatment of sickle-cell disease. In particular, the invention provides 5-membered heterocyclic anti-sickling agents that are highly effective and non-toxic, and methods for their use. The compounds include analogues and derivatives of naturally occurring occurring 5-hydroxymethyl-2-furfuraldehyde, 5-Ethyl-2-furfuraldehyde, 5-Methyl-2-furfuraldehyde, and 2-furfuraldehyde, and prodrug forms of the compound.

Abstract: Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals The invention relates to diarylcycloalkyl derivatives and to their physiologically acceptable salts, racemates and physiologically functional derivatives. What is described are compounds of the formula I, in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparation. The compounds are suitable for the treatment and/or prevention of disorders of fatty acid metabolism and glucose utilization disorders as well as of disorders in which insulin resistence is involved.

Abstract: The present invention relates to novel oxazolidinone compounds of formula (I), their stereoisomers, their salts and pharmaceutical compositions containing them. The present invention also relates to a process for the preparation of the above said novel compounds, their stereoisomers, their salts and pharmaceutical compositions.

Abstract: The efficacy of levodopa therapy in patients being treated for Parkinson's disease is enhanced by administering high doses of a partial glycine agonist. The frequency and severity of levodopa-induced side effects in Parkinson's disease patients are also reduced by administration of a partial glycine agonist.

Abstract: Asymmetric derivatives of furamidines with one of the phenyl rings of furamidine replaced with a benzimidazole have been found by quantitative footprinting analyses to bind GC containing sites on DNA more strongly than to pure AT sequences. These compounds have been shown to bind in the minor groove at specific GC containing sequences of DNA in a highly cooperative manner as a stacked dimer. Compounds of the present invention find use in selectively binding mixed sequence DNA, and may also be used in methods of regulating gene expression, methods of treating opportunistic infections and cancer, as well as in methods of detecting certain sequences of DNA.

Abstract: The present invention relates to N-methyl-substituted benzamidazole derivatives of formula (I): as defined in the specification; pharmaceutical compositions and methods of use thereof.

Abstract: This invention features a method for enhancing bone growth or inhibiting bone resportion. The method includes administering to a subject in need thereof a compound of the following formula: A is H, R, or each of Ar1, Ar2, and Ar3, independently, is phenyl, thienyl, furyl, or pyrrolyl; each of R1, R2, R3, R4, R5, and R6, independently, is H, halogen, R, C(O)OH, C(O)OR, C(O)SH, C(O)SR, C(O)NH2, C(O)NHR, C(O)NRR?, ROH, ROR?, RSH, RSR?, NHR, NRR?, RNHR?, or RNR?R?; or R1 and R2 together, R3 and R4 together, or R5 and R6 together are ORO; wherein each of R, R?, and R?, independently is C1˜C6 alkyl; and n is 1, 2, or 3.

Abstract: The present invention relates to spirobenzofuran lactam derivatives of the formula I which are formed during fermentation by the microorganism Stachybotris atra ST002348, DSM 14952, processes for their preparation, their use as pharmaceuticals, and the microorganism Stachybotris atra ST002348, DSM 14952.

Abstract: This invention provides indole oxo-acetyl amino acetic acid derivatives which are useful as inhibitors of plasminogen activator inhibitor-1 (PAI-1) useful for treating fibrinolytic disorders, the compounds having the structure: wherein: R1 is alkyl or optionally substituted cycloalkyl, —CH2-cycloalkyl, pyridinyl, —CH2-pyridinyl, phenyl or benzyl; R2 is hydrogen, alkyl, cycloalkyl, —CH2-cycloalkyl, or perfluoroalkyl; R3 is hydrogen, halo, alkyl, perfluoroalkyl, alkoxy, cycloalkyl, —CH2-cycloalkyl, —NH2, or —NO2; R4 is optionally substituted phenyl, benzyl, benzyloxy, pyridinyl, or —CH2-pyridinyl; R8 is hydrogen, alkyl, cycloalkyl, —CH2-cycloalkyl, perfluoroalkyl, aryl, substituted aryl, alkyl-aryl, or substituted alkyl-aryl; R9 is hydrogen, alkyl, hydroxyalkyl, 4-hydroxybenzyl, 3-indolylymethylene, 4-imidazolylmethylene, HSCH2—, CH3SCH2CH2—, H2NC(?O)CH2—, H2NC(?O)CH2CH2—, HO2CCH2—, HO2CCH2CH2—, H2NCH2CH2CH2CH2—, H2NC(?NH)NHCH2CH2CH2—, or taken together with R8 as —CH2CH2CH2—; or a pharmaceutically acceptab

Abstract: A taxane having the formula: wherein X3 is furyl, X5 is t-butoxycarbonyl, Bz is benzoyl, and Ac is acetyl.

Abstract: Disclosed are (i) compounds of a steroid, a ?-agonist, an anticholinergic, a mast cell stabilizer and a phosphodiesterase (PDE) inhibitor directly or indirectly linked to a NO or NO2 group or a group which stimulates endogenous production of NO or EDRF in vivo; (ii) compositions of steroids, ?-agonists, anticholinergics, mast cell stabilizers and PDE inhibitors, which can optionally be substituted with at least one NO or NO2 moiety or a group which stimulates endogenous production of NO or EDRF in vivo, and a compound that donates, transfers or releases nitric oxide as a charged species, i.e., nitrosonium (NO+) or nitroxyl (NO?), or as the neutral species, nitric oxide (NO.) or that stimulates endogenous production of NO or EDRF in vivo; and (iii) uses for them in preventing and/or treating respiratory disorders.

Abstract: Mammalian hair growth can be reduced by topical application of an inhibitor of fatty acid metabolism.

Abstract: The present invention provides crystalline biphenyl-4-carboxylic acid (R)-(6-(1-((4-fluorobenzyl)methylamino)ethylideneamino)-2(R)-hydroxyindan-1-yl)amide hemihydrate, compositions thereof, methods of using the same, processes for making the same, and processes for making intermediates thereof.

Abstract: Novel inhibitors of polyamine transport having inhibition constants two orders of magnitude lower than those of known compounds are disclosed. These polyamine analogues are useful pharmaceutical agents for treating diseases where it is desired to inhibit polyamine transport or other polyamine binding proteins, for example cancer and post-angioplasty injury. Novel chemical synthetic methods to obtain polyamine analogues are disclosed, including the production of a combinatiorial polyamine library. These approaches yield analogues with desirable activities both for diagnostic and research assays and therapy. The assays of the invention are useful for high throughput screening of targets in the discovery of drugs that interact with the polyamine system.

Abstract: The present invention broadly relates to the field of protein modification, and, more specifically, to conjugates of proteins or analogs thereof to a water-soluble biocompatible polymer and methods of making and using the same.

Abstract: Use of a compound having a hydrophobic moiety attached to a hydrophilic moiety, wherein the hydrophilic moiety comprises a ?-keto acid group and the hydrophobic moiety is attached via a bond from a carbon or an oxygen of the hydrophobic moiety to a carbon of the ?-keto acid group, provided that the ?-carbon of the ?-keto acid group does not form part of a carboxyl or ester group, or a salt thereof, as a surfactant. A dispersion comprising said surfactant as a dispersing agent. A method for breaking a dispersion comprising said surfactant as a dispersing agent, said method comprising the steps of a) providing said dispersion at a temperature where it is substantially stable; and b) setting the temperature of said dispersion, so as to achieve a desired decomposition rate of the surfactant.

Abstract: An ion exchange fluorocarbon resin membrane having a storage modulus (JIS K-7244), when substituted with tributyl ammonium ions, at a temperature of not less than Tc represented by the following general equations (1-1) to (1-3) of 0.8×106 Pa or more, and a heat of crystal fusion at 270 to 350° C. of 1 J/g or less: Tc (° C.)=55+Tg (EW<750)??(1-1) Tc (° C.)=0.444×EW?278+Tg (750?EW<930)??(1-2) Tc (° C.)=135+Tg (EW?930)??(1-3) where Tg designates the peak temperature of loss tangent in the dynamic viscoelasticity measure-ment of the ion exchange fluorocarbon resin membrane (having SO3H as the ends of the side chains).

Abstract: Porous matrices and membrane matrices comprising sulfonated aryl sulfonate polymers are prepared from a sulfonated aryl sulfonate polymer solution which is made by dissolving an aryl sulfonate polymer, and optionally a polymer other than aryl sulfonate, in a sulfonating acid solvent such as sulfuric acid. The solutions are then cast as wet films from which the matrices are coagulated. By controlling composition and process parameters, hydrophilic matrices of varying morphology are produced.

Abstract: Methods are provided to make acid functional fluoropolymers by: a) dehydrofluorinating a starting fluoropolymer with a dehydrofluorinating agent to form an unsaturated fluoropolymer; b) adding an acidifiable nucleophilic functionalizing agent to a double bond of the unsaturated fluoropolymer; and c) acidifying the added acidifiable function. Acid functional fluoropolymers and ion conducting membranes thereof are also provided, including acid functional fluoropolymer having pendent groups according to the formula: —X—Ar—An, wherein X is selected from O, S or NR, where R is selected from H and C1–C30 alkyl or aryl, which are optionally substituted, wherein Ar is a C6–C30 aromatic group, which is optionally substituted, wherein A is an acidic function or salt thereof, wherein a can be independently chosen to be 1, 2 or 3.

Abstract: U.S. Pat. No. 6,232,354 issued May 15, 2001 describes an environmentally friendly and commercially practicable process for the production of microcellular polymer foams from amorphous, semi-crystalline and crystalline polymers which involves consolidating the polymer, saturating the polymer with an inert gas at elevated temperature and under elevated pressure, and controllably cooling, i.e. quenching the saturated polymer under a variety of temperature and pressure conditions to produce either a closed or open celled microcellular foam or a high density microcellular foam. It has now been discovered that a process similar to that described in this patent can be used for the production of nanocomposite and molecular-composite foams that exhibit exceptional physical properties.

Abstract: A composition and a method for producing primarily water blown polyurethane foams is provided. The composition uses isocyanate ratios greater than conventional foam system to provide a water blown polyurethane foam suitable for a wide variety of applications including spray roofing, insulation, etc. The preferred composition for preparing a polyurethane foam comprises an isocyanate component and a polyol component, wherein the polyol component preferably comprises a combination of Mannich polyol, polyester polyol, and polyether polyol. Preferably, the composition includes water to act as a blowing agent and a metal salt catalyst to assist in the reaction. Preferably, the isocyanate index is between about 1.2 and about 2.0. Additional catalysts, surfactants, flame retardants, and blowing agents may also be used depending upon the desired finished product.

Abstract: The invention relates to the use of a thermal reversible gel, such as a copolymer composition, as a biological filler or implant. The gel has a semi-solid form at body temperature, but upon cooling to a temperature below a threshold level, the gel is liquefied and can be re-shaped, re-sized, manipulated or removed from the body. The gel may be used as a subcutaneous implant, a biological filler, joint or tissue spacer, for wrinkle filling or other cosmetic implants, as a soft-tissue replacement for reconstructive surgery, or as a barrier within the lumen of a biological structure, such as a blood vessel. The implant may be used to provide reversible birth control by providing, for example, a reversible barrier to the cervix or a reversible blockage of the lumen of the vas deferens.

Abstract: Bone cements containing polyacrylates or polymethacrylates and an X-ray contrast medium can be prepared by functionalizing the X-ray contrast medium with (meth)acrylate groups prior to being coating with melamine-formaldehyde resin and subsequent polymerization. The invention resultant bone cement can be used for anchoring prosthesis components in bone, for stiffening bone, as bone screw fixing plug and as implants for anchoring screws.

Abstract: This invention relates to an ink composition (and a method of printing therewith) comprising water, a humectant, and polymer-dye particles, wherein said polymer-dye particles comprise a colorant phase containing a water insoluble dye of formula (I), and a polymer phase, said particles being associated with a co-stabilizer wherein R1 is a substituent as described in the application; R2 is a substituent as described in the application; R3 has a Pi of 0 to 1.5; and R4 has a Pi of greater than or equal to 0.6.

Abstract: Ink for ink-jet recording contains an oil soluble dye, a humectant, a penetrant, water, and an amphiphilic star block polymer of which the outer portion is hydrophilic. The surface tension of the ink at 25° C. is in the range of 20 to 50 mN/m.

Abstract: Polymeric modified asphalt for road paving applications wherein the polymer modifier is a tubular reactor produced ethylene/alkyl acrylate copolymer (e.g., EMA) optionally blended with an epoxy functionalized ethylene copolymer (e.g., EnBAGMA) and added to the asphalt with or without the use of an acid adjuvant (e.g., PSA).

Abstract: An ultraviolet radiation absorbent for thermoplastic polymer materials such as polyethylene terephthalate or polycarbonate contains cyclic imino ester compound of a specified structure in an amount of over 99.5 weight % and less than 100 weight % and having an acid value in the range of 1×10?3–1 and/or a chlorine ion content in the range of 1×10?1–1×103 ppm.

Abstract: An aromatic polycarbonate resin composition having: 100 parts by weight of a resin component (A) mainly having an aromatic polycarbonate, 0.1 to 200 parts by weight of a solid inorganic compound (B), at least one compound (C) selected from the group consisting of an organic acid, an organic acid ester, and an organic acid anhydride, 0.001 to 1 part by weight of at least one organic acid metal salt (D) selected from the group consisting of an organic acid alkali metal salt and an organic acid alkaline earth metal salt, and 0.01 to 1 part by weight of a fluoropolymer (E), wherein compound (C) is present in an amount wherein a mixture of compounds (B) and (C) exhibits a pH value of from 4 to 8.

Abstract: A lubricating/detaching/fluidifying additive composition for organic polymers is described, comprising a saturated hydrocarbon having from 25 to 35 carbon atoms with at least three side substituents consisting of a methyl group, combined with at least one polysiloxane polymer having a molecular weight higher than 500,000. The use of this composition or single hydrocarbon component as lubricating/detaching/fluidifying additive for organic polymers, is also described, together with a polymeric composition containing additives, comprising an organic polymer and the additive composition. The use according to the present invention is particularly advantageous as it is universal (the same additive for all organic polymers, regardless of their formulation); it allows the use of high viscosity/high M.W. polymers (suitable for extrusion), also in injection moulding, and enables the additive to be applied externally to the polymer.

Abstract: A compound permitting the economic production of packaging containers, which when activated produces concentrated amounts of CO2 gas for extended periods for preservation of perishable products therein, comprises a mixture including a CO2 generating portion incorporated within a polymer matrix. Preferably, the mixture includes citric acid; calcium carbonate, and polyethylene resin. More preferably, the mixture includes a mixture of a carboxylic acid (0.1–40%); a hydrogen carbonate (0.1–40%) and any polyolefin resin. Even more preferably, the mixture includes a mixture including (0.01–40%) Citric Acid; (0.01–40%); and 30–75% polyethylene resin. Most preferably, the mixture includes by weight 12% citric acid; 38% calcium carbonate; and 50% low density polyethylene resin with a melt index of 20 and a density of 0.924 g/cc. Alternatively, the carboxylic acid and hydrogen carbonate components are compounded into separate polymer matrixes, and later combined.

Abstract: In a multi-piece solid golf ball comprising a solid core, a mantle and a cover, the solid core is made of a rubber composition that includes a base rubber containing a polybutadiene synthesized using a rare-earth catalyst, a small amount of organic peroxide, an unsaturated carboxylic acid and/or a metal salt thereof, an organic sulfur compound and an inorganic filler. The mantle is made of a thermoplastic resin composition. The cover is made primarily of a thermoplastic polyurethane material. This construction provides the golf ball with a combination of outstanding flight performance and soft feel with cover's scuff resistance and coating's abrasion resistance, that is unprecedented.

Abstract: A dental composite material that comprises a polyhedral oligomeric silsesquioxane is disclosed. The dental composite material is useful for a variety of dental materials, treatments, and restorative functions including crown and bridge materials, fillings, adhesives, sealants, luting agents or cements, denture base materials, orthodontic materials and sealants, and other dental restorative materials.

Abstract: Polymer-phyllosilicate nanocomposites that exhibit superior properties compared to the polymer alone, and methods-for producing these polymer-phyllosilicate nanocomposites, are provided. Polymeric surfactant compatabilizers are adsorbed onto the surface of hydrophilic or natural phyllosilicates to facilitate the dispersal and exfoliation of the phyllosilicate in a polymer matrix. Utilizing polymeric glycol based surfactants, polymeric dicarboxylic acids, polymeric diammonium surfactants, and polymeric diamine surfactants as compatabilizers facilitates natural phyllosilicate and hydrophilic organoclay dispersal in a polymer matrix to produce nanocomposites.

Abstract: A fluid or semifluid additive composition useful for asphalt paving comprises between about 10% and about 50% crumb rubber, about 10% and about 50% petroleum hydrocarbon having at least about 50% aromatics, between about 10% and about 50% surface active clay, and water, by weight.

Abstract: A process for making an aqueous emulsion of polyolefin employs a functionalized emulsification facilitating compound. The aqueous emulsion can be used to prepare a hybrid polyolefin-polyurethane dispersion useful, inter alia, as an adhesion-promoting coating for polymers such as the polyolefins.

Abstract: The present invention provides a film-forming composition comprising a particulate polymer or emulsified liquid pre-polymer, water and a coalescent aid comprising an ester having the formula RCOOX wherein R and X are independently hydrocarbyl or substituted hydrocarbyl, and at least one of R and X contain at least two unsaturated carbon—carbon bonds. The coalescent aid helps lower the minimum film formation temperature of low glass transition temperature coatings and high glass transition temperature coatings and allows optimum film formation at ambient temperatures. The coalescent aid of this coating composition is not volatile like conventional coalescent aids but rather remains part of the film and air oxidizes to cure the film. This coating composition also exhibits properties of adhesion and gloss superior to that of coating compositions containing conventional coalescent aids. Additionally, this coalescent aid can be made from natural or synthetic oils.

Abstract: A method for improving the cohesive strength at elevated temperature of a die attach adhesive formulation of a liquid curable resin, initiator, and filler, comprises adding to the adhesive formulation an aromatic bismaleimide resin powder that does not dissolve in the curable resin.

Abstract: Graft copolymers providing soil release benefits in laundry detergent compositions contain backbone units derived from an ethylenically unsaturated monomer, hydrophilic uncharged side chains, and cationically chargeable or charged side chains containing a tertiary or quaternary nitrogen atom. Preferred copolymers have a methacrylate backbone with polyethylene oxide and 2-dimethylaminoethyl methacrylate (DMAEMA) side chains. The graft copolymers may be prepared by radical polymerisation.

Abstract: The object of the present invention is to provide a polymer alloy including polylactic acid which can be used in the same manner as conventional commodity plastics even in an environment of high temperature and high humidity. According to the present invention, there is provided a polymer alloy including polylactic acid comprising (A) a polylactic acid, (B) a polyalkylacrylic ester and/or a polyvinyl ester, (C) a polyolefin and (D) a block copolymer of a polyalkylacrylic ester and polyolefin and/or a block copolymer of a polyvinyl ester and a polyolefin.

Abstract: Olefin block copolymers (A-1) are disclosed represented by the formula (I) PO1-g1-B1 . . . (I) wherein PO1 is a segment comprised of repeating units derived from an olefin having 2 to 20 carbon atoms, g1 is an ester, ether, amide, imide, urethane, urea, silylether or carbonyl linkage, and B1 is a segment containing an unsaturated hydrocarbon or a hetero atom. The olefin block copolymers are suitable for uses in adhesives, various molded articles such as construction and civil engineering materials, automobile interior and exterior materials, gasoline tanks, electric and electronic parts, medical care and sanitation materials, materials of miscellaneous goods, resin materials having environmental degradation properties, films and sheets, modifiers and dispersions.

Abstract: A modified olefin-based copolymer produced by graft-polymerizing an alkenyl aromatic hydrocarbon and/or an unsaturated carboxylic acid or derivative thereof to an olefin-based copolymer containing repeating units derived from a linear ?-olefin and/or ethylene copolymer of ethylene and repeating units derived from a vinyl compound (I) or (II) described below, and an adhesive containing the product as an effective ingredient, in which an adhesiveness to an adherend such as olefin resins (e.g. polyethylene, polypropylene) is further improved, are provided. Vinyl compound (I): a vinyl compound represented by the general formula CH2?CH—R, wherein steric parameters Es and B1 of the substituent R are respectively ?1.64 or less and 1.53 or more. Vinyl compound (II): a vinyl compound represented by the general formula CH2?CH—R?, wherein a substituent R? is a secondary or tertiary alkyl group.

Abstract: The invention relates to peroxide compositions comprising a reactive diluent for the peroxide, wherein the diluent is either a component containing one or more vinyl ether group(s) and having a monomeric structure according to formula 1, (A—CH?CH—O)n—R, or is a suitable resinous compound comprising, in a covalently built-in manner, a component containing one or more vinyl ether group(s). In the formula A represents hydrogen or an alkyl group with 1–3 C atoms, and individual A groups may be different R either represents an aliphatic group, optionally branched, with 1–20 C atoms, etc. ?or represents a polyethylene or polypropylene glycol with 2 to 120 glycol units, etc. and n is 1, 2, 3 or 4.

Abstract: The present invention relates to a linear block copolymer and a process for preparing the same, particularly to a linear block copolymer and a process for preparing the same which can improve transmissivity of a block copolymer and remarkably lower a Haze value by introducing a vinyl aromatic hydrocarbon to conduct primary polymerization, simultaneously introducing a vinyl aromatic hydrocarbon and a conjugated diene monomer therein to conduct secondary polymerization, and introducing a vinyl aromatic hydrocarbon therein to conduct tertiary polymerization, thereby locating a conjugated diene/vinyl aromatic hydrocarbon copolymer block in a block copolymer.